Is CV Sciences Inc (CVSI) Stock About to Get Hot Wednesday?

CV Sciences Inc (CVSI) stock is flat 0.00% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

CV Sciences Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on CVSI!

See Full CVSI Report

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With CVSI Stock Today?

CV Sciences Inc (CVSI) stock is flat -2.7% while the S&P 500 has fallen -0.25% as of 11:22 AM on Wednesday, Nov 8. CVSI is unchanged $0.00 from the previous closing price of $0.04 on volume of 42,242 shares. Over the past year the S&P 500 is up 14.72% while CVSI is unchanged 0.00%. CVSI earned $0.01 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 5.35. To screen for more stocks like CV Sciences Inc click here.

More About CV Sciences Inc

CV Sciences Inc is a pharmaceutical company. The group operates in two segments consumer products and specialty pharmaceutical. The consumer products segment develops, manufactures and markets products based on hemp-based Cannabidiol (CBD). Whereas the specialty pharmaceutical segment is developing drug candidates which use CBD as a primary active ingredient. Click Here to get the full Stock Report for CV Sciences Inc stock.